Thromboelastography Promising as Risk Assessment for VTE in Women’s Cancers
Thromboelastography (TEG) was studied as a tool for evaluating venous thromboembolism (VTE) risk in female cancer patients undergoing chemotherapy. TEG parameters were used to assess hypercoagulability, with 63% of patients showing this after the first cycle and 75% after the second cycle. Patients with ovarian cancer had higher TEG values compared to those with breast…